Published January 2015
| Version v1
Book
Biotinylation of Immunoglobulins
Description
The biotinylation of monoclonal antibodies (MAbs) represents a useful tool to prepare in house MAbs containing a number of biotin molecules, which do not compromise the MAb immunoreactivity, and can be used as a first step in the pretargeting approach, which foresees as a final step the intravenous injection of radiolabelled biotin
Additional details
Identifiers
Publishing Information
- Publisher
- IAEA
- Imprint Place
- Vienna (International Atomic Energy Agency (IAEA))
- ISBN
- 978-92-0-103814-2
- Imprint Title
- Yttrium-90 and Rhenium-188 Radiopharmaceuticals for Radionuclide Therapy
- Imprint Pagination
- 320 p.
- Journal Issue
- no. 5
- Series
- IAEA Radioisotopes and Radiopharmaceuticals Series
- Journal Page Range
- p. 293-294
- ISSN
- 2077-6462
INIS
- Country of Publication
- International Atomic Energy Agency (IAEA)
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 46044158
- Subject category
- S38: RADIATION CHEMISTRY, RADIOCHEMISTRY AND NUCLEAR CHEMISTRY;
- Descriptors DEI
- BIOTIN; BRACHYTHERAPY; IMMUNOGLOBULINS; INTRAVENOUS INJECTION; LABELLED COMPOUNDS; MOLECULES; MONOCLONAL ANTIBODIES; RADIOPHARMACEUTICALS
- Descriptors DEC
- ANTIBODIES; AZOLES; CARBOXYLIC ACIDS; DRUGS; GLOBULINS; HETEROCYCLIC ACIDS; HETEROCYCLIC COMPOUNDS; IMIDAZOLES; INJECTION; INTAKE; LABELLED COMPOUNDS; MATERIALS; MEDICINE; NUCLEAR MEDICINE; ORGANIC ACIDS; ORGANIC COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; ORGANIC SULFUR COMPOUNDS; PROTEINS; RADIOACTIVE MATERIALS; RADIOLOGY; RADIOTHERAPY; THERAPY; VITAMIN B GROUP; VITAMINS
Optional Information
- Secondary number(s)
- STI/PUB--1662